Rep. Kevin Hern (R-Okla.) has disclosed a sale of Organon & Co. (OGN) common stock, according to a Periodic Transaction Report filed under the STOCK Act. The transaction, valued between $1,001 and $15,000, was made through a jointly-held account tied to Hern and his spouse, and was executed via the Hern Family Revocable Trust.
The sale took place on August 5, 2026, and falls under the disclosure category the site classifies as a congress sale — a transaction reported because it meets the reporting thresholds required of members of Congress under federal ethics law. The STOCK Act requires lawmakers to disclose trades like this one within 45 days, regardless of size, so the public filing itself is a routine compliance matter rather than an indication of any wrongdoing.
An Insider Sale on the Same Day
What makes this filing notable is its timing relative to activity inside Organon itself. Company insider Drinane Juliana Papa also sold OGN shares on the same date, August 5, 2026, in a transaction valued at $200,307. Both sales were reported within the same 30-day disclosure window, putting a congressional trade and a corporate insider trade on the same stock on the same calendar day into public view at roughly the same time.
There is no indication in either filing that the two transactions are connected, and STOCK Act disclosures do not require lawmakers or corporate insiders to explain their reasoning for a trade. Still, when a member of Congress and a company insider report selling the same security on the same date, it tends to draw attention simply because of the coincidence in timing, and readers tracking OGN activity may want to note both data points side by side.
Hern’s transaction was routed through the Hern Family Revocable Trust, a structure commonly used by members of Congress to hold jointly-owned assets. Because the trade was made in a jointly-held account, it reflects holdings attributed to both Hern and his spouse rather than an individual brokerage position.
For additional background on this specific filing and the surrounding context, the site’s earlier coverage, Kevin Hern Discloses Joint OGN Sale Amid Insider Selling, goes into more detail on the disclosure as it was first reported.
As with all STOCK Act filings, this report is a matter of public record and reflects a legal disclosure obligation rather than a suggestion about the merits of holding or trading OGN shares. Readers are encouraged to view the underlying filing directly for full details of the transaction.